| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/09/1989 | WO1989001027A1 Lipid microemulsions for culture media |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents |
| 02/09/1989 | WO1989000810A1 Asexual induction of heritable male sterility and apomixis in plants |
| 02/09/1989 | WO1989000202A3 Method for producing novel polyester biopolymers |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/09/1989 | DE3825492A1 Verfahren zur herstellung von hybridsamen A method for hybrid seed production |
| 02/09/1989 | DE3710309A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 02/08/1989 | EP0302838A2 Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme |
| 02/08/1989 | EP0302801A1 Vaccines of which the characteristic epitope is incorporated in a picorna virus protein, particularly in that of the polio virus |
| 02/08/1989 | EP0302758A1 Viral expression inhibitors |
| 02/08/1989 | EP0302456A1 New tissue plasminogen activator |
| 02/08/1989 | EP0302381A1 A fused gene having aequorin gene linked to a functional B-galactosidase gene |
| 02/08/1989 | EP0302175A2 Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same |
| 02/08/1989 | EP0302103A1 Colony stimulating factors having reduced levels of carbohydrate |
| 02/08/1989 | CN1030940A Particle-mediated transformation of soybean plants and lines |
| 02/08/1989 | CN1030939A Promoter for expression of exogenous dna in methyltrophic bacteria, process for preparing same and theiruse |
| 02/07/1989 | US4803169 Assay for human breast cancer |
| 02/07/1989 | US4803168 Capsules for viable cells |
| 02/07/1989 | US4803166 Microorganism for degrading toxic waste materials |
| 02/07/1989 | US4803165 Nif promoter of fast-growing rhizobium japonicum |
| 02/07/1989 | US4803164 Kinase promoter |
| 02/07/1989 | US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa |
| 02/02/1989 | DE3823712A1 Method of transferring genes into plants |
| 02/02/1989 | DE3724442A1 Verfahren und vorrichtung zur reinigung von m-13-phagen-dna Method and apparatus for the purification of M-13 phage DNA |
| 02/02/1989 | DE3724027A1 Verfahren zur nitrifikation, einen hierfuer geeigneten mikroorganismus sowie die im mikroorganismus enthaltene plasmid-dna Method for nitrification, here for a suitable microorganism and the plasmid-dna contained in the micro-organism |
| 02/02/1989 | DE3724016A1 Methods for the genetic engineering production of antigens and their use in an approach to confirmatory tests for antibodies in the example of human immunodeficiency virus (HIV) |
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections |
| 02/01/1989 | EP0301968A1 Human papilloma virus nucleic acid probes |
| 02/01/1989 | EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications |
| 02/01/1989 | EP0301954A2 Cloning method and expression of genes constituting functional organised structures |
| 02/01/1989 | EP0301899A2 Nucleic acid capture reagent |
| 02/01/1989 | EP0301749A2 Particle-mediated transformation of soybean plants and lines |
| 02/01/1989 | EP0301670A1 Kluyveromyces as a host strain |
| 02/01/1989 | EP0301669A1 DNA constructs containing a Kluyveromyces alpha-factor leader sequence for directing secretion of heterologous derivatives |
| 02/01/1989 | EP0301667A1 Method for the immunoassay of apolipoproteins |
| 02/01/1989 | EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH |
| 02/01/1989 | EP0301484A1 PTH modifications and therapeutic compositions containing them or consisting of them |
| 02/01/1989 | EP0301316A2 Method of gene transfer in plants |
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 |
| 02/01/1989 | EP0301083A1 Retroviral expression vectors and methods for producing hbv antigens |
| 02/01/1989 | EP0138948B1 Dna sequence encoding an exo-signal |
| 02/01/1989 | CN1030788A Method of gene transfer into plants |
| 02/01/1989 | CN1030787A Molecular cloning and expression of genes encoding proteolytic enzymes |
| 01/31/1989 | US4801686 Suspension, microbial cells, breaking, extraction |
| 01/31/1989 | US4801542 Expression of biologically active PDGF analogs in eucaryotic cells |
| 01/31/1989 | US4801541 Method of increasing the yield of a product by altering a microorganism |
| 01/31/1989 | US4801540 Modulation of polygalactouronase expression |
| 01/31/1989 | US4801537 Vector for expression of polypeptides in bacilli |
| 01/31/1989 | US4801536 Method for producing heterologous proteins |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000605A1 Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same |
| 01/26/1989 | WO1989000604A1 Method for improving translation efficiency |
| 01/26/1989 | WO1989000603A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
| 01/26/1989 | WO1989000602A1 Process for gene transfer in plants |
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000579A1 Purification of gm-csf |
| 01/26/1989 | WO1989000577A1 Digestion method |
| 01/26/1989 | WO1989000547A1 Process for nitrification and nitrogen removal by nitrifying bacteria |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/26/1989 | EP0227795A4 Method for performing nucleic acid hybridization assays. |
| 01/26/1989 | DE3722884A1 Human manganese superoxide dismutase (hMn-SOD) |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300796A2 Amplification method for polynucleotide assays |
| 01/25/1989 | EP0300687A2 Method of inhibiting human immunodeficiency virus |
| 01/25/1989 | EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins |
| 01/25/1989 | EP0300466A1 Characterization and structure of genes for protease A and protease B from streptomyces griseus |
| 01/25/1989 | EP0300459A2 Human pancreatic secretory trypsin inhibitor |
| 01/25/1989 | EP0300425A2 Method for the production of proteins in a soluble form |
| 01/25/1989 | EP0300422A2 An improved method for preparing stable and viable recombinant animal cell viral vectors |
| 01/25/1989 | EP0300298A2 Method for the enlargement of the cell specificity of eukaryotic expression vectors |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300168A2 Process for the glutathione synthesis in yeast |
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity |
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens |
| 01/25/1989 | CN1030611A Monoclonal antibody specific for adhesion function domain of phagocyte cell surface protein |
| 01/25/1989 | CN1030610A Monoclonal antibody specific to common determinant site of neutrophils and eosinophils |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone |
| 01/24/1989 | US4800158 To 6-methyl-5-hepten-2-one |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/19/1989 | DE3722958A1 Method for the identification and/or isolation of specific molecules or populations of molecules |
| 01/19/1989 | DE3710430A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/19/1989 | DE3710364A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/18/1989 | EP0299878A1 Enzymatic technique using a lyophilised chromogen, kit and method of lyophilisation |
| 01/18/1989 | EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/18/1989 | EP0299810A1 Process for the production of polypeptides by recombinant DNA |
| 01/18/1989 | EP0299790A2 Recombinant C-terminal alpha-amidating enzyme |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |
| 01/18/1989 | EP0299746A1 Purification of GM-CSF |
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation |
| 01/18/1989 | EP0299682A1 DNA sequence coding for HRP enzyme |
| 01/18/1989 | EP0299558A1 Process for the preparation of ibuprofen |
| 01/18/1989 | EP0299552A1 A process for transforming cells |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299303A2 Eucaryotic expression vectors with multimeric enhancer subelements, process for their preparation and use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/18/1989 | EP0299206A2 Recombinant human ADF |
| 01/18/1989 | EP0299127A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |